TR&D 2

$36,168P41FY2017EBNIH

Columbia University Health Sciences, New York NY

Investigators

Linked publications & trials

Paper 38633084 Paper 34399973 Paper 33100611 Paper 31899616 Paper 31875032 Paper 30850209 Paper 30555854 Paper 30524014 Paper 29954325 Paper 29515291 Paper 29479127 Paper 29170564 Paper 28795608 Paper 28283188 Paper 28170315 Paper 28140791 Paper 28140790 Paper 27194954 Paper 26207682 Paper 25883782 Paper 25870435 Paper 25800676 Paper 25335641 Paper 25234738 Paper 25072018 Paper 24409041 Paper 24392197 Paper 24198200 Paper 24080278 Paper 24058378 Paper 23995963 Paper 23942865 Paper 23742552 Paper 23708525 Paper 23420504 Paper 23387672 Paper 22738761 Paper 22545061 Paper 21811347 Paper 21486161 Paper 21440540 Paper 21205307 Paper 21149323 Paper 21149295 Paper 21143185 Paper 21131327 Paper 21106636 Paper 20842121 Paper 20670442 Paper 20634916 Paper 20574841 Paper 20545568 Paper 20206688 Paper 20161365 Paper 19820460 Paper 19779218 Paper 19679136 Paper 19577658 Paper 19536557 Paper 19499238 Paper 19454800 Paper 19346688 Paper 19346684 Paper 19346682 Paper 19123569 Paper 18725109 Paper 18667402 Paper 18088188 Paper 17971581 Paper 17897680 Paper 17534357 Paper 17522030 Paper 17483342 Paper 17189277 Paper 17179481 Paper 17164279 Paper 16238443 Paper 16170376 Paper 16162670 Paper 15824734 Paper 15273333

Abstract

The microbeam technology developed at RARAF over the last 20 years allows precise irradiation of single cells within a culture or in suspension. There has been growing demand amongst microbeam users to match this capability with technologies to perform analyses on a single cell basis. This is driven mostly by the increasing interest in cell-to-cell variations in damage response. In this TR&D we will develop tools for quantification in single cells, of gene expression, oxidative stress, and chemical structure.

View original record on NIH RePORTER →